Zealand Pharma CEO predicts complex future for obesity treatments
Weight-loss drugs will need to do more than just reduce body weight, says Adam Steensberg. ”It’ll be more complex than just weight loss.”
by peter thomsen, translated by daniel pedersen
When the pharmaceutical industry will assess the business case for obesity treatments in the future, it will hardly only be an evaluation of how many kilos can be lost on respective products – effects on comorbidities like diabetes, cardiovascular disease, and cancer will also be considered.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
